Clinical Trial Update: Validate Gene Expression and Proteomic Signatures Predictive of Treatment for Response for Breast Cancer Patient [Phase 2]

View source ↗

Summary

This clinical trial update describes a Phase 2 study to validate gene expression and proteomic signatures that predict treatment response in breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: National University Hospital, Singapore | Conditions: Breast Cancer | Phase 2 | Status: UNKNOWN